Cite
Silva de Castro I, Gorini G, Mason R, et al. Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates. iScience. 2021;24(2):102047doi: 10.1016/j.isci.2021.102047.
Silva de Castro, I., Gorini, G., Mason, R., Gorman, J., Bissa, M., Rahman, M. A., Arakelyan, A., Kalisz, I., Whitney, S., Becerra-Flores, M., Ni, E., Peachman, K., Trinh, H. V., Read, M., Liu, M. H., Van Ryk, D., Paquin-Proulx, D., Shubin, Z., Tuyishime, M., Peele, J., Ahmadi, M. S., Verardi, R., Hill, J., Beddall, M., Nguyen, R., Stamos, J. D., Fujikawa, D., Min, S., Schifanella, L., Vaccari, M., Galli, V., Doster, M. N., Liyanage, N. P. M., Sarkis, S., Caccuri, F., LaBranche, C., Montefiori, D. C., Tomaras, G. D., Shen, X., Rosati, M., Felber, B. K., Pavlakis, G. N., Venzon, D. J., Magnanelli, W., Breed, M., Kramer, J., Keele, B. F., Eller, M. A., Cicala, C., Arthos, J., Ferrari, G., Margolis, L., Robert-Guroff, M., Kwong, P. D., Roederer, M., Rao, M., Cardozo, T. J., & Franchini, G. (2021). Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates. iScience, 24(2), 102047. https://doi.org/10.1016/j.isci.2021.102047
Silva de Castro, Isabela, et al. "Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates." iScience vol. 24,2 (2021): 102047. doi: https://doi.org/10.1016/j.isci.2021.102047
Silva de Castro I, Gorini G, Mason R, Gorman J, Bissa M, Rahman MA, Arakelyan A, Kalisz I, Whitney S, Becerra-Flores M, Ni E, Peachman K, Trinh HV, Read M, Liu MH, Van Ryk D, Paquin-Proulx D, Shubin Z, Tuyishime M, Peele J, Ahmadi MS, Verardi R, Hill J, Beddall M, Nguyen R, Stamos JD, Fujikawa D, Min S, Schifanella L, Vaccari M, Galli V, Doster MN, Liyanage NPM, Sarkis S, Caccuri F, LaBranche C, Montefiori DC, Tomaras GD, Shen X, Rosati M, Felber BK, Pavlakis GN, Venzon DJ, Magnanelli W, Breed M, Kramer J, Keele BF, Eller MA, Cicala C, Arthos J, Ferrari G, Margolis L, Robert-Guroff M, Kwong PD, Roederer M, Rao M, Cardozo TJ, Franchini G. Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates. iScience. 2021 Jan 09;24(2):102047. doi: 10.1016/j.isci.2021.102047. eCollection 2021 Feb 19. PMID: 33554060; PMCID: PMC7847973.
Copy
Download .nbib